Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Gynecologic Oncology

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.YGYNO.2006.10.060PMID 17208284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positron emission tomography in gynecologic cancer.

  2006cited by this paper
• The impact of PET/CT in the management of recurrent ovarian cancer.

  2006cited by this paper
• Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.

  2005cited by this paper
• Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.

  2005cited by this paper
• Monitoring response to treatment in patients utilizing PET.

  2005cited by this paper
• Oncologic PET/CT: current status and controversies

  2005cited by this paper
• (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.

  2005cited by this paper
• Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer.

  2005cited by this paper
• Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings.

  2004cited by this paper
• PET/CT today and tomorrow.

  2004cited by this paper
• Cancer Statistics, 2004

  2004cited by this paper
• Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT.

  2003cited by this paper
• Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.

  2002cited by this paper
• Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings.

  2002cited by this paper
• Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose

  2002cited by this paper
• Cytoreductive surgery for advanced stages of ovarian cancer.

  2000cited by this paper
• Metabolische Charakterisierung von Ovarialtumoren mit der Positronen-Emissions-Tomographie und F-18-Fluordeoxyglukose

  1997cited by this paper
• Use of CA 125 in follow-up of ovarian cancer.

  1996cited by this paper
• Use of CA 125 in follow-up of ovarian cancer

  1996cited by this paper
• Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan.

  1995cited by this paper
• Cancer of the ovary.

  1993cited by this paper

• ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update.

  2025cites this paper
• Imaging of Peritoneal Metastases in Ovarian Cancer Using MDCT, MRI, and FDG PET/CT: A Systematic Review and Meta-Analysis

  2024cites this paper
• PET/Computed Tomography Transformation of Oncology: Ovarian Cancers.

  2024cites this paper
• The role of PET/CT with fluorine-18-deoxyglucose in the detection of relapsed serous ovarian cancer in patients with normal serum CA125 levels.

  2023cites this paper
• The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma

  2023cites this paper
• 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

  2023cites this paper
• Hyperpolarized Carbon 13 MRI: Clinical Applications and Future Directions in Oncology.

  2023cites this paper
• Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.

  2023cites this paper
• Investigation of 18F-FDG PET/CT Findings and CA-125 Levels in Ovarian Cancer Staging

  2022cites this paper
• Multiparameter MRI Radiomics Model Predicts Preoperative Peritoneal Carcinomatosis in Ovarian Cancer

  2021cites this paper
• Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma—a literature review

  2020cites this paper
• Increased circulating tumor DNA as a noninvasive biomarker of early treatment response in patients with metastatic ovarian carcinoma: A pilot study

  2020cites this paper
• Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers

  2020cites this paper
• Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: a multicentre study of the FRANCOGYN research group.

  2020cites this paper
• Usefulness of PET–CT in the evaluation of suspected recurrent ovarian carcinoma

  2019cites this paper
• PET/CT for Evaluation of Ovarian Cancer.

  2019cites this paper
• Patterns of initially overlooked recurrence of peritoneal lesions in patients with advanced ovarian cancer on postoperative multi-detector row CT

  2019cites this paper
• Magnetic Resonance imaging of tumour biomarkers in ovarian cancer

  2019cites this paper
• Multimodality imaging and genomics of granulosa cell tumors

  2019cites this paper
• Evaluation of Recurrent Ovarian Cancer: An Evolution

  2019cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Surgical Management of Recurrent Epithelial Ovarian Cancer

  2018cites this paper
• Mathematical approaches for the clinical translation of hyperpolarised 13C imaging in oncology

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer STAGING AND FOLLOW-UP OF OVARIAN CANCER Expert Panel on Women’s Imaging: Stella

  2018cites this paper
• Additional Role 18F-FDG PET/CT in Detection of Ovarian Recurrence or Metastatic Lesions.

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Dendrimer-Based Nanoplatforms for SPECT Imaging Applications

  2018cites this paper
• Chapter 9 – Gynecologic Cancers

  2018cites this paper
• Three-Dimensional Highly Sensitive Diffusion Reflection-Based Imaging Method for the in Vivo Localization of Atherosclerosis Plaques Following Gold Nanorods Accumulation

  2018cites this paper
• Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis

  2018cites this paper
• Intraperitoneal chemotherapy for ovarian cancer using sustained-release implantable devices

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Diagnostic value of integrated 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer.

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• The Prognostic Value of 18F-FDG PET/CT in Monitoring Chemotherapy in Ovarian Cancer Both at Initial Diagnosis and at Recurrent Disease.

  2018cites this paper
• 11 – Epithelial Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• Staging and Follow-up of Ovarian Cancer

  2018cites this paper
• An update on the role of PET/CT and PET/MRI in ovarian cancer

  2017cites this paper
• FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls.

  2017cites this paper
• Pozytonowa tomografia emisyjna – znaczenie w ginekologii

  2017cites this paper
• Accuracy of 18F-FDG PET/CT in detection and restaging of recurrent ovarian cancer

  2017cites this paper
• Tuulia Vallius: NOVEL PREDICTORS OF RESPONSE AND OUTCOME IN ADVANCED EPITHELIAL OVARIAN CANCER

  2017cites this paper
• Prediction of therapy response in ovarian cancer: Where are we now?

  2017cites this paper
• The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.

  2017cites this paper
• Diagnostic value of positron emission tomography (PET) and PET/computed tomography in recurrent/metastatic ovarian cancer: A meta‐analysis

  2017cites this paper
• Diagnostic Applications of Nuclear Medicine: Ovarian Cancer

  2016cites this paper
• Survivorship of Gynecologic Malignancy

  2016cites this paper
• Staging and Follow-up of Ovarian Cancer

  2016cites this paper
• Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent

  2016cites this paper
• Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging.

  2016cites this paper
• Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy

  2016cites this paper
• Molecular Imaging of Ovarian Cancer

  2016cites this paper
• Nuclear medicine for imaging of epithelial ovarian cancer.

  2016cites this paper
• Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery

  2015cites this paper
• Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level

  2015cites this paper
• F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer

  2015cites this paper
• Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review

  2015cites this paper
• Avaliação radiológica do carcinoma do ovário

  2015cites this paper
• Appropriateness criteria of FDG PET/CT in oncology

  2015cites this paper
• HE4 in the differential diagnosis of ovarian masses.

  2015cites this paper
• Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer

  2014cites this paper
• Is there an impact of 18F-FDG PET/CT on the surveillance and clinical management of recurrent ovarian cancer? Research based on a large sample in a single PET/CT center

  2014cites this paper
• The effectiveness of dual-phase 18F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot study

  2014cites this paper